Submit your paper
EDPS Account
Login
All issues
About
Search
Menu
All issues
About the journal
Aims and scope
Editorial board
Ethical standards
Indexed in
Copyright and License agreement
Masthead
Author information
Instructions for authors
Article Processing Charges
Submit your paper
Reader's services
News
Advanced Search
All issues
Volume 7 / No 4 (December 2017)
BioMedicine, 7 4 (2017) 23
Full HTML
All issues
About the journal
Aims and scope
Editorial board
Ethical standards
Indexed in
Copyright and License agreement
Masthead
Author information
Instructions for authors
Article Processing Charges
Submit your paper
Reader's services
News
Open Access
Review
Fig. 1
Download original image
Chemical structures of anti-tumour agents with clinical applications.
Homepage
Table of Contents
Previous article
Next article
Article
Abstract
Full HTML
PDF (593.6 KB)
ePUB (872.7 KB)
References
PubMed Record
Services
Articles citing this article
CrossRef (118)
PubMed Central
Same authors
-
Google Scholar
-
EDP Sciences database
-
PubMed
Recommend this article
Send to my Kindle
Download citation
Related Articles
New Approved First-line Combining Therapy of NSCLC in 2020
E3S Web of Conferences 245, 03057 (2021)
Thérapies moléculaires ciblées : l’exemple de l’Iressa®(ZD1839)
Med Sci (Paris) 2003 ; 19 : 1052–1054
YC-1 induces G0/G1 phase arrest and mitochondria-dependent apoptosis in cisplatin-resistant human oral cancer CAR cells
BioMedicine (June 2017) 7:12
Prédiction de la réponse à l’Iressa® : un mécanisme inattendu
Med Sci (Paris) 2004 ; 20 : 750–751
The impact of competition between cancer cells and healthy cells on optimal drug delivery
Math. Model. Nat. Phenom. 15 (2020) 42
More
Bookmarking
Mendeley
Reader's services
Email-alert